Every night, the online Belgian patent register ('eRegister') receives an update with public data that were entered or generated the preceding day on the Benelux Patent Platform, the computer application with which the Belgian Intellectual Property Office handles the registration, treatment and publication processes for patents and supplementary protection certificates.
Currently, some updates are spread over consecutive nights due to the large, weekly volume of data concerning European patents designating Belgium.
For a European patent it is possible that data about the inventor(s) are missing from the online Belgian patent register. They can be found via the link to the European patent register pending an update of the Belgian patent register.
For European patents with Unitary Effect, the authentic source of information is the European Patent Register : please refer to it.

Patent details

3114139 Title: ANTICORPS CONTRE EOTAXIN-2 RECONNAISSANT DES CHEMOKINES SUPPLEMENTAIRES SE LIANTS À CCR3

The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents

Basic information

Application number:
157149634
WO application number:
IL2015050234
Type:
European patent granted for BE
Status:
Open
Publication number:
3114139
WO publication number:
WO2015132790
1rst applicant's nationality:
Translation language:
EPO publication language:
English
SPC number:

Dates

Filing date:
04/03/2015
Grant date:
15/06/2022
EP publication date:
11/01/2017
WO publication date:
11/09/2015
Claims translation received date:
Translation received date (EP publication B1):
Translation received date (EP publication B2):
Translation received date (EP publication B3):
Registration date:
15/06/2022
EP B1 publication date:
15/06/2022
EP B2 publication date:
EP B3 publication date:
Lapsed date:
Expiration date (if granted and all annual fees paid):
04/03/2035

Applicant

Name:
Chemomab Ltd.
Legal Form:
From:
15/06/2022
Address:
Kiryat Aditim, Building 7, Entrance B, 6158002 Tel Aviv, Israel (IL)
To:

Agent

Name:
POLVERARI Luca
Legal Form:
From:
08/09/2022
Address:
44, rue de la Vallée B.P. 1775, 1017, LUXEMBOURG, Luxembourg (LU)
To:

Inventor

Name:
MOR, Adi
Legal Form:
Address:
6901872 Tel Aviv, Israel (IL)

Priority

Priority patent number:
201461947852 P
Priority date:
04/03/2014
Priority country:
United States (US)

Classification

IPC or IDT classification:
C07K 16/24; C12N 15/13; A61K 39/395; A61P 37/00;

Publication

Bulletin

Bulletin heading:
EP2
Journal edition number:
2022/11
Publication date:
23/06/2022
Description:
Contains data concerning European patents granted and published (B1 publication) for Belgium and for which no translation needed to be filed

European Patent Bulletin

Issue number:
202224
Publication date:
15/06/2022
Description:
Grant (B1)

Annual fee

Annual fee(s) Due Date:
31/03/2027
Annual fee number:
13
Annual fee amount:
275 Euro
Expected payer:
Last annual fee payment date:
17/03/2026
Last annual fee paid number:
12
Last annual fee paid amount:
240 Euro
Payer:
C.P.A.
Filing date Document type Publication Type Document Description Number of pages File Type
08/09/2022 Outgoing Correspondence 1 PDF /0/5/3/2/3/0722232350/docs/157149634_0_outgoingcorrespondence_20220909_084600109.pdf
08/09/2022 Incoming Correspondence (Email) Cover letter 1 PDF /0/5/3/2/3/0722232350/docs/157149634_1_incomingcorrespondenceelectronic_20220909_084600330.pdf
08/09/2022 General Document Declaration of domicile 1 PDF /0/5/3/2/3/0722232350/docs/157149634_2_generaldocument_20220909_084600222.pdf